Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label, Single Arm, Multi-Centered Study To Evaluate The Efficacy, Safety And Tolerability Of Lipid Based Tacrolimus Ointment 0.1% Of Intas Pharmaceuticals Limited, India In Patients of Oral Lichen Planus

Trial Profile

An Open-Label, Single Arm, Multi-Centered Study To Evaluate The Efficacy, Safety And Tolerability Of Lipid Based Tacrolimus Ointment 0.1% Of Intas Pharmaceuticals Limited, India In Patients of Oral Lichen Planus

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2018

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Lichen planus
  • Focus Registrational; Therapeutic Use
  • Sponsors Intas Pharmaceuticals
  • Most Recent Events

    • 22 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top